Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Allergy & Immunology
•
Drug Allergy
Are drug challenges after serum sickness-like reactions useful in delabeling the allergy?
Answer from: at Community Practice
Too unpredictable each time.
Sign In
or
Register
to read more
30563
Related Questions
How do you approach hypogammaglobulinemia in a patient with sarcoidosis?
What medications would you have a patient avoid with an IgE mediated reaction to cyclobenzaprine?
Can a patient with a previous reaction to IV iron dextran take oral iron supplements without concern for adverse reactions?
In light of recent measles outbreaks in the US, would you recommend an MMR booster for an immunocompetent patients born before 1957?
How do you advise patients to avoid carboxymethylcellulose when the excipient it is commonly found in many products?
Would you consider prescribing NAC for a patient with OCD and a documented sulfa allergy?
Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?
Would you proceed to a direct penicillin challenge in a patient with a reaction history 30+ years ago without any further clinical history?
If a patient had an allergic reaction to one GLP-1, does it preclude the use of another?
What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?